Zee Media Bureau
New Delhi: The Supreme Court on Saturday issued notice to Centre and Ranbaxy on a PIL seeking probe against the company for allegedly supplying adulterated drugs in the country.
The apex court, however, refused to pass interim order to restrain Ranbaxy from manufacturing drugs.
Reacting to this, the firm's shares fell by 4.09 percent to Rs 340.45 apiece on the BSE.
Zee News App: Read latest news of India and world, bollywood news, business updates, cricket scores, etc. Download the Zee news app now to keep up with daily breaking news and live news event coverage.
